Oncostellae

Oncostellae is a clinical-stage biopharmaceutical company that discovers and develops proprietary small-molecule drug candidates for immunology and oncology. The firm manages drug development from initial conception through Phase I/II clinical trials before licensing commercialization rights to established pharmaceutical companies. Its current pipeline focuses on addressing high unmet medical needs in inflammatory diseases and cancer treatment.